Reflections On The Past For Investors Today: Vigil Neuroscience Inc (NASDAQ: VIGL)

Vigil Neuroscience Inc (NASDAQ:VIGL) does about 114.71K shares in volume on a normal day but saw 2381890 shares change hands in Friday’s trading. The company now has a market cap of 172.87M USD. Its current market price is $4.60, marking an increase of 7.48% compared to the previous close of $4.28. The 52 week high reached by this stock is $11.11 whilst the lowest price level in 52 weeks is $2.47.

Vigil Neuroscience Inc (VIGL) has a 20-day trading average at $3.46 and the current price is -58.60% off the 52-week high compared with 86.23% distance from its 52-week low. The 50-day simple moving average of the closing price is $3.21 and its 200-day simple moving average is $4.16. If we look at the stock’s price movements over the week, volatility stands at 28.79%, which decreases to 15.25% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 66.50 to suggest the stock is neutral.

The consensus objective for the share price is $16.75, suggesting that the stock has a potential upside of 72.54% over the period.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on December 19, 2023 when Morgan Stanley downgraded the stock to “Underweight” and issued a price target of between $13 and $4. Mizuho initiated its price target at $15.

Vigil Neuroscience Inc (VIGL) stock is up 44.65% over the week and 21.69% over the past month. Its price is 36.09% year-to-date and -54.00% over the past year.

The stock last released its quarterly earnings report for quarter ended 3/31/2024, with the company’s earnings per share (EPS) of -0.52 above consensus estimates by 0.02. The company’s next earnings report forecasts estimating quarterly EPS at -0.55 and -1.92 for whole year.

To reach the target analysts have set, the stock logically needs to grow 72.54 percent from here.

The company has a return on investment of -71.07% and return on equity of -60.18%. The beta has a value of 1.98. Price to book ratio is 1.67.